Bacterial and fungal cell wall component (None in common use; scientific literature generally refers to individual components (e.g., peptidoglycan, chitin, glucan) rather than a combined abbreviation)

Molecular Classification

Other (not a receptor, enzyme, transporter, etc.; composed of structural polysaccharides and glycoproteins), Polysaccharide matrix, Glycoprotein complex, Scaffold structure

Other Names

Bacterial cell wall, Fungal cell wall, Peptidoglycan (bacteria-specific), Chitin, β-(1,3)-glucan, mannoproteins, GPI-anchored proteins (fungi-specific)

Disease Roles

Infection (bacterial, fungal)Drug resistanceInflammation (host immune response)

Bacterial and fungal cell wall component Overview

Bacterial and fungal cell wall components comprise the structural exoskeletons surrounding microbial cells, crucial for the maintenance of cell shape, protection from environmental threats, and osmotic regulation. In bacteria, the cell wall is primarily composed of peptidoglycan, a macromolecular lattice unique to prokaryotes and the principal target of classic antibiotics such as β-lactams and glycopeptides. Fungal cell walls, by contrast, consist mainly of chitin, β-(1,3)-glucan and β-(1,6)-glucan, mannoproteins, and glycosylphosphatidylinositol (GPI)-anchored proteins. These components confer rigidity, mediate adhesion, contribute to immune evasion, and are unique to fungi, making them prime targets for antifungal drugs like echinocandins and investigational agents such as ibrexafungerp and nikkomycin Z. Both bacterial and fungal cell wall targets offer avenues for antimicrobial therapy and diagnostic biomarker development. However, cell wall plasticity and biosynthetic redundancy in these organisms can complicate treatment efficacy and drive drug resistance.

Mechanism of Action

Inhibition of cell wall biosynthesis enzymes (β-glucan synthase, chitin synthase, transpeptidases) Disruption of cell wall integrity leading to cell lysis Inhibition of glycosylation or anchor biosynthesis pathways (GPI) Immune system targeting exposed components, exploiting unmaksed wall antigens

Biological Functions

Structural support and rigidity

Protection from environmental stress

Osmotic regulation

Cell adhesion (via specific wall proteins)

Immune evasion and recognition

Disease Associations

Infection (bacterial, fungal)

Drug resistance

Inflammation (host immune response)

Other (biofilm formation, virulence)

Safety Considerations

Potential for off-target toxicity (especially with non-specific agents)
Resistance development via compensatory wall biosynthesis/remodeling
Hypersensitivity reactions (e.g., β-lactam allergy)
Some cell wall inhibitors (e.g., echinocandins) can trigger cell wall stress responses, leading to drug tolerance
Challenge in selectively targeting fungal components without affecting human cells (note: humans lack these components, limiting intrinsic toxicity)

Interacting Drugs

Antibacterials targeting peptidoglycan: β-lactams (penicillins, cephalosporins), glycopeptides (vancomycin)

Antifungals targeting glucan or chitin synthesis: Echinocandins (caspofungin, micafungin), ibrexafungerp, nikkomycin Z, polyoxin

Investigational drugs: GPI anchor pathway inhibitors (APX001A), novel β-glucan synthase inhibitors

Associated Biomarkers

Biomarker
β-(1,3)-D-glucan (diagnostic for fungal infections, especially invasive)
Anti-Bgl2 antibodies (potential biomarker for candidiasis)
Mannan/mannoprotein antigen detection in serum (fungal)
Peptidoglycan detection (bacterial sepsis)